Director
DIN: 09858079
Bijendra Pratap Singh is currently associated with 2 companies in various capacities such as Director, Individual Promoter and Individual Subscriber. They serve as a Director at OSHONIC DERMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09858079.Bijendra Pratap Singh is currently involved in 3 different roles. Their most recent position is with EMERALD MEDICITY PRIVATE LIMITED as a Individual Subscriber. The first company Bijendra Pratap Singh was appointed to as a director was OSHONIC DERMA PRIVATE LIMITED. Bijendra Pratap Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Bijendra Pratap Singh is currently associated with 2 companies in various capacities such as Director, Individual Promoter and Individual Subscriber. They serve as a Director at OSHONIC DERMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09858079.Bijendra Pratap Singh is currently involved in 3 different roles. Their most recent position is with EMERALD MEDICITY PRIVATE LIMITED as a Individual Subscriber. The first company Bijendra Pratap Singh was appointed to as a director was OSHONIC DERMA PRIVATE LIMITED. Bijendra Pratap Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
9 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| OSHONIC DERMA PRIVATE LIMITED | Director | 11-Jan-2023 |
| OSHONIC DERMA PRIVATE LIMITED | Individual Promoter | 11-Jan-2023 |
| EMERALD MEDICITY PRIVATE LIMITED | Individual Subscriber | 01-Feb-2024 |